Please write a SOAP note for a 45-year-old patient with no chronic illnesses, no egg allergy, and no contraindications who is receiving an annual quadrivalent inactivated influenza vaccine.

SOAP Note for Influenza Vaccination

Subjective

• 45-year-old patient presents for annual influenza vaccination
• No chronic medical conditions
• No egg allergy
• No contraindications to influenza vaccine
• No history of severe allergic reaction to previous influenza vaccines
• No history of Guillain-Barré syndrome within 6 weeks of prior influenza vaccination

Objective

• Vital signs: Stable
• General appearance: Well-appearing, no acute distress
• Injection site: Left/right deltoid area examined, no contraindications to intramuscular injection

Assessment

Patient is an appropriate candidate for quadrivalent inactivated influenza vaccine (IIV4) for the current influenza season. 1

The Advisory Committee on Immunization Practices (ACIP) recommends routine annual influenza vaccination for all persons aged ≥6 months who do not have contraindications 1. For this healthy 45-year-old adult with no contraindications, any age-appropriate IIV4 product is suitable 2.

Key clinical considerations:

• No egg allergy precautions needed, though vaccine is egg-based 3
• No history of severe allergic reactions to vaccine components
• Standard 0.5 mL intramuscular dose appropriate for adults 3
• Single annual dose provides adequate protection 2

Plan

Vaccination Administration

• Administer 0.5 mL quadrivalent inactivated influenza vaccine (IIV4) intramuscularly in the deltoid muscle 3
• Vaccine contains 15 mcg hemagglutinin (HA) of each of the four recommended influenza strains for the current season 3
• Document vaccine lot number, expiration date, manufacturer, and administration site in medical record

Post-Vaccination Monitoring

• Observe patient for 15 minutes post-vaccination for any immediate adverse reactions
• Most common expected adverse events: injection site soreness, redness, mild systemic symptoms (fatigue, headache, myalgia) 3

Patient Education

• Inform patient that immune response peaks at 2-4 weeks post-vaccination 4
• Advise that mild injection site pain and systemic symptoms may occur but typically resolve within 1-2 days
• Instruct to seek medical attention if signs of severe allergic reaction develop (rare)
• Emphasize importance of annual influenza vaccination

Follow-up

• Return for annual influenza vaccination next season
• No routine follow-up needed unless adverse reactions occur

Vaccine administered without complications. Patient tolerated procedure well.